Sales & Marketing News | pharmaphorum

News

Datavant, Aetion merger creates real-world data force

Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle.

News

MSD adds new indication for Welireg in rare tumours

MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare solid tumour PPGL or 'pheo para'.

News

AbbVie bags first approval for cancer ADC Emrelis

AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis.

News

Sanofi pledges a $20 billion investment programme in the US

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US.

News

RFK Jr defends HHS cuts, measles stance in Congress hearings

HHS Secretary Robert F Kennedy Jr would not explicitly endorse measles vaccines at Congressional hearings, and deflected questions on department cuts.

News

EC's von der Leyen loses bid to stop disclosure of Pfizer te...

Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer's CEO on COVID-19 vaccine procurement.

Datavant, Aetion merger creates real-world data force

MSD adds new indication for Welireg in rare tumours

AbbVie bags first approval for cancer ADC Emrelis

Sanofi pledges a $20 billion investment programme in the US

RFK Jr defends HHS cuts, measles stance in Congress hearings

EC's von der Leyen loses bid to stop disclosure of Pfizer te...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks